Bellerophon Therapeutics Financials

We suggest to use Bellerophon Therapeutics fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if Bellerophon Therapeutics is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate data for thirty-four available fundamental indicators for Bellerophon Therapeutics, which can be compared to its peers.
  
Understanding current and past Bellerophon Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bellerophon Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Bellerophon Therapeutics' assets may result in an increase in income on the income statement.

Bellerophon Therapeutics Stock Summary

Bellerophon Therapeutics competes with Bio Path, Capricor Therapeutics, NextCure, Zura Bio, and Immix Biopharma. Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey. Bellerophon Ther operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 20 people.
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
ISINUS0787713009
Business Address184 Liberty Corner
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.bellerophon.com
Phone908 574 4770
CurrencyUSD - US Dollar

Bellerophon Therapeutics Key Financial Ratios

Bellerophon Therapeutics' financial ratios allow both analysts and investors to convert raw data from Bellerophon Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of Bellerophon Therapeutics over time and compare it to other companies across industries.

Bellerophon Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bellerophon Therapeutics's current stock value. Our valuation model uses many indicators to compare Bellerophon Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bellerophon Therapeutics competition to find correlations between indicators driving Bellerophon Therapeutics's intrinsic value. More Info.
Bellerophon Therapeutics is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bellerophon Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bellerophon Therapeutics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Consideration for investing in Bellerophon Pink Sheet

If you are still planning to invest in Bellerophon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellerophon Therapeutics' history and understand the potential risks before investing.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stocks Directory
Find actively traded stocks across global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like